The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of Parkinson's medication.
31 January 2017Read More
Global Kinetics Corporation is pleased to be working with neurologist and Parkinson's UK-funded researcher. Dr Alastair Noyce from the Institute of Neurology, University College London, to help spot e…
04 January 2017Read More
Global Kinetics Corporation has secured CE marking on its second generation Parkinson’s KinetiGraph™ (PKG™) System, indicating that the product complies with EU health and safety requirements and legi…
16 December 2016Read More
Global Kinetics Corporation and uMotif have announced a new partnership bringing together two leading proprietary products to provide a unique data capture platform for Parkinson’s research.